Patent details

EP3102605 Title: COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3102605
WO Application Number:
US2015014212
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP15703439.8
WO Publication Number:
WO2015119930
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
03/02/2015
Grant date:
14/11/2018
EP Publication Date:
14/12/2016
WO Publication Date:
13/08/2015
Claims Translations Received Date:
Claims Translation B1 Received Date:
05/02/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/11/2018
EP B1 Publication Date:
14/11/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
02/02/2035
Lapsed By Expiration Date:
Patent Validated Date:
14/03/2019
Revocation Date:
11/01/2024
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
11/08/2023
 
 

 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, 10001-2192, New York, NY, United States of America (US)

From:
11/08/2023
 
 

 

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Avenue P.O. Box 2000, 07065, Rahway, New Jersey, United States of America (US)

Historical Applicant/holder

From:
11/08/2023
To:
11/08/2023

 

Name:
Pfizer Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)

From:
14/11/2018
To:
11/08/2023

 

Name:
Pfizer Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)

From:
14/11/2018
To:
11/08/2023

 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, RAHWAY, NJ 07065, United States of America (US)

Agent

Name:
J.M.H. Duyver lic.
From:
13/03/2019
Address:
Gevers Patents Holidaystraat 5, B-1831, Diegem, Belgium (BE)
To:

Inventor

1

Name:
MARTINI, Jean-francois, Andre
Address:
Carlsbad, CA 92009, United States of America (US)

2

Name:
TARAZI, Jamal, Christo
Address:
San Diego, CA 92124, United States of America (US)

3

Name:
PERINI, Rodolfo, Fleury
Address:
Philadelphia, PA 19146, United States of America (US)

4

Name:
MAURO, David, J.
Address:
North Wales, PA 19454, United States of America (US)

Priority

Priority Patent Number:
201461935809 P
Priority Date:
04/02/2014
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/4439; A61K 39/395; A61P 35/00; C07K 16/28;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
09/24
Publication date:
28/02/2024
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
36/23
Publication date:
06/09/2023
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
VB1
Journal edition number:
38/19
Publication date:
18/09/2019
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

4

Bulletin Heading:
EP3
Journal edition number:
12/19
Publication date:
20/03/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
47/18
Publication date:
14/11/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202409
Publication date:
28/02/2024
Description:
Revocation of the European patent

2

Issue number:
201938
Publication date:
18/09/2019
Description:
Opposition procedure started

3

Issue number:
201851
Publication date:
19/12/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:
201846
Publication date:
14/11/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC202301723A
Date Registered:
11/08/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
J.M.H. Duyver lic.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Pfizer Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)

2

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Avenue P.O. Box 2000, 07065, Rahway, New Jersey, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202301723B
Date Registered:
11/08/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
J.M.H. Duyver lic.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
15/12/2023
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
13/03/2019 Outgoing Correspondence Letter no formal defects 1 PDF /9/0/1/0/4/0800340109/docs/ep15703439.8_1_258907l271.pdf
05/02/2019 Claims First filed claims 3 PDF /9/0/1/0/4/0800340109/docs/ep15703439.8_0_claims20190205151708422.pdf